A hair transplant moves hair follicles from the back and sides of your scalp — where they are genetically resistant to the hormones that cause hair loss — to areas that are thinning or bald. It does not create new hair. It redistributes existing hair. That one fact determines everything about whether the procedure makes sense for you.
Many people who want a hair transplant are not good candidates, at least not yet. Some never will be. Knowing where you stand before you book a consultation can save you thousands of dollars, protect the donor supply you may need later, and prevent a result that looks worse over time, not better.
The Five Questions That Determine Candidacy
Surgeons and researchers consistently evaluate five factors to determine whether a patient should have a hair transplant. All five matter. A clinic that only asks about one or two of them is not doing its job.
1. What is causing your hair loss?
The most common cause of hair loss — and the one hair transplantation was designed to treat — is androgenetic alopecia, also called male pattern or female pattern hair loss. It is driven by genetics and hormonal sensitivity and follows predictable patterns that surgeons can plan around.
Not all hair loss works this way. Several types are either contraindications to surgery or require resolution before surgery can be considered:
- Cicatricial (scarring) alopecia — conditions such as lichen planopilaris and discoid lupus erythematosus — destroys follicles through inflammation. Operating on an inflamed scalp is likely to fail and may worsen the disease. Transplantation is typically not considered until the condition has been inactive for two years.
- Alopecia areata is autoimmune. The immune system attacks follicles unpredictably, and transplanted follicles face the same risk.
- Diffuse unpatterned alopecia (DUPA) is the most critical condition to rule out. It looks similar to androgenetic alopecia in early stages but involves thinning across the entire scalp, including the donor zone at the back. If a surgeon harvests follicles from a donor area that is itself destined to thin, the transplanted hair will eventually fall out. DUPA cannot be diagnosed from a photo or mirror. It requires dermoscopy or trichoscopy — specialized scalp examinations.
Thyroid disease, iron deficiency, recent childbirth, and certain medications can also cause hair loss that may resolve on its own with treatment. These should be ruled out before surgery is scheduled.
2. Do you have enough donor hair?
The donor zone is not unlimited. Every follicle removed is permanently gone from that site. A responsible surgeon plans not only for your current bald area but for the hair loss you will experience over the next several decades.
Donor density is typically measured using dermoscopy. The safe donor zone in the back of the scalp usually contains 65 to 85 follicular units per square centimeter. Densities above 80 units per cm² are favorable; below 40 is generally insufficient. If more than 20 percent of follicles in the donor area are miniaturized — meaning already beginning to thin — surgery is typically not recommended.
Hair texture matters too. Coarser, wavier hair covers more surface area per graft than fine, straight hair. Patients with fine hair may not have enough supply to meet their coverage goals.
3. Has your hair loss stabilized?
Transplanting into an actively progressing pattern creates a predictable problem: the moved hair stays, but the surrounding native hair continues to fall out, leaving the transplanted grafts isolated in a growing bald area.
Clinicians look at how quickly loss has progressed and measure the degree of miniaturization in the area to be treated. When miniaturization in the recipient zone exceeds 15 percent, there is a meaningful risk of shock loss — a temporary or permanent shedding of existing hair triggered by surgical trauma. In cases of rapid progression, a 6 to 12 month course of medical therapy is typically recommended before surgery is considered.
4. How old are you, and what does your family history suggest?
Patients under 25 present a specific challenge. Their loss is often still progressing, and the final extent of their pattern cannot yet be predicted. A surgeon who places a dense, low hairline on a 22-year-old whose crown continues to bald over the next ten years may produce a result that looks increasingly unnatural with time.
For most patients under 25, the standard recommendation is to delay surgery and use medical therapy until the pattern stabilizes. Age is not disqualifying on its own — what matters is whether the pattern is stable enough to plan around.
5. What do you expect the surgery to accomplish?
Unrealistic expectations are documented in the clinical literature as a leading cause of post-operative dissatisfaction — independent of how well the surgery went technically.
A hair transplant does not restore the density you had before you started losing hair. The goal is to create an appearance of density in targeted areas. Some scalp will still be visible in certain lighting. Scarring exists, whether microscopic in FUE procedures or linear in FUT. Native hair around the transplanted zone will continue to thin unless treated with medication.
Special Considerations for Women
Female candidacy is more complicated than male candidacy, and most content in this space understates that.
The key distinction is between diffuse patterned alopecia (DPA) — where thinning follows a pattern while the donor zone at the back of the scalp remains stable — and DUPA, where thinning spreads throughout the entire scalp, including the donor zone. Women are more likely than men to have DUPA. This is the primary reason the proportion of women who are good surgical candidates is smaller than many assume.
Before a woman can be evaluated for candidacy, her donor zone must be examined with a densitometer or trichoscopy to confirm the follicles there are healthy and stable. If the donor zone is compromised, surgery will not produce lasting results, and medical therapy is the appropriate path.
Women with confirmed androgenetic alopecia, a stable, patterned distribution of thinning, and a healthy donor zone can be excellent candidates. Women with active thyroid disorders, hormonal imbalances, or recent pregnancy-related shedding should address those conditions first — the hair loss may improve without surgery.
Conditions That Rule Out Surgery, Either Temporarily or Permanently
Several conditions are recognized in peer-reviewed literature as making a patient an inappropriate candidate. Surgeons who practice responsibly will decline to operate in these cases. A clinic that never raises any of these in consultation is worth approaching with caution.
DUPA
No reliable donor zone means no basis for surgery. Transplanted follicles will eventually thin along with the rest.
Active scarring alopecia
Surgery into an inflamed scalp risks worsening the disease and will produce no lasting result.
Unstable or rapidly progressing hair loss
Without medical stabilization first, surgery is likely to produce a result that deteriorates quickly.
Mild, early-stage thinning
Patients in the early stages of loss typically benefit more from medical therapy than from a procedure that depletes donor supply they may need later.
Uncontrolled systemic illness
Severe cardiovascular disease, uncontrolled diabetes, serious bleeding disorders, and significant liver or kidney disease all increase surgical risk to a level that makes an elective procedure inappropriate.
Body dysmorphic disorder (BDD)
BDD is a psychiatric condition in which a person is preoccupied with a perceived physical flaw that is absent or minor to outside observers. Patients with BDD are very likely to remain dissatisfied after surgery regardless of the technical result, and surgery can intensify the fixation rather than resolve it. Studies report BDD prevalence among cosmetic surgery patients at 6 to 15 percent — not a rare edge case. Ethical pre-operative screening should assess for BDD using a validated tool such as the Body Dysmorphic Disorder Questionnaire.
Trichotillomania
This is a compulsive hair-pulling disorder that can produce a balding pattern resembling androgenetic alopecia. Surgery should be deferred until the condition is under psychological treatment and has stabilized.
Active smoking without willingness to stop
Nicotine constricts blood vessels and impairs healing, which reduces graft survival. Cessation for at least three to four weeks before and after surgery is standard guidance.
What a Responsible Consultation Looks Like
A thorough pre-operative evaluation should include all of the following. Use this as a checklist when you meet with a surgeon.
- A complete medical and hair-specific history, including when loss started, how fast it has progressed, family history, current medications, and any prior treatments.
- Examination of the entire scalp — donor zone and recipient zone — not only the area you are concerned about.
- Dermoscopy or trichoscopy to assess follicle health and miniaturization in both areas.
- A discussion of your likely hair loss trajectory over the next 10 to 20 years, not just your current pattern.
- An explanation of what the procedure can and cannot accomplish, and what will happen to native (untransplanted) hair over time.
- A question about whether you have tried medical therapy.
On Medical Therapy
Finasteride (typically for men) and minoxidil (for men and women) are the two best-evidenced medications for androgenetic alopecia. In the context of candidacy, they serve two roles: they may slow or stop loss progression enough to make surgery unnecessary, and they are often required to stabilize the scalp before surgery can be safely performed.
After surgery, medical therapy is typically recommended to maintain the native hair surrounding the transplanted zone. The transplant itself does not stop ongoing loss in follicles that were not moved.
A Question Worth Sitting With
Before scheduling a consultation, consider this: if the surgeon told you that you are not a candidate and offered a medical therapy plan instead, would you consider that a useful outcome — or would you feel the visit was a failure?
If the honest answer is the latter, it is worth thinking through what you are looking for. Surgery works best when it is the right tool for the clinical situation, not the fastest available path to an answer.
Sources
- Bernstein Medical. Are You a Hair Transplant Candidate? Updated March 2025.
- Unger R. & Shapiro R. Is Every Patient of Hair Loss a Candidate for Hair Transplant? PMC, 2021. PMC8719975.
- Zito P.M. & Raggio B.S. Hair Transplantation. StatPearls, NIH, 2024. NBK547740.
- Brinks et al. Hair Transplant: Patient Candidacy, Medical Optimization, and Surgical Considerations. International Journal of Dermatology, 2025. doi:10.1111/ijd.17961.
- Association of Hair Restoration Surgeons of India. Hair Transplant Practice Guidelines. J Cutan Aesthet Surg, 2021. PMC8611706.
- Tan et al. Psychological Dimensions of Hair Transplantation. Journal of Cosmetic Dermatology, 2025. doi:10.1111/jocd.70475.
- Hair Transplant Forum International. Body Dysmorphic Disorder in Hair Loss Patients. ISHRS, 2012. 22(4):133.
